Compare Aromasin vs. Femara

Head-to-head comparisons of medication uses, side effects, ratings, and more.

ADVERTISEMENT
No information currently available
No information currently available
Upsides
No information currently available
No information currently available
Downsides
No information currently available
No information currently available
ADVERTISEMENT
Used for
  • Breast cancer
  • Adjuvant
  • Postmenopausal
  • Estrogen receptor-positive
  • Following 2 to 3 years of adjuvant tamoxifen Breast cancer
  • Advanced
  • Postmenopausal
  • Following progression on tamoxifen therapy
  • Breast cancer
  • Invasive
  • In postmenopausal women at increased risk; Prophylaxis Breast cancer
  • Neoadjuvant
  • Postmenopausal
  • Hormone-receptor positive
  • Breast cancer
  • Adjuvant
  • Postmenopausal
  • Hormone receptor-positive Breast cancer
  • Advanced
  • Postmenopausal
  • Following antiestrogen therapy Breast cancer
  • Extended adjuvant
  • Postmenopausal
  • Following 5 years of tamoxifen therapy Breast cancer
  • Locally advanced or metastatic
  • Postmenopausal
  • Hormone receptor-positive or unknown
  • First-line
  • Breast cancer
  • Neoadjuvant
  • Postmenopausal
  • Hormone receptor-positive Delayed puberty Endometriosis - Ovulation induction Ovulation induction - Polycystic ovary syndrome
Dosage forms
  • Pill
  • Pill
Price
Want to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
The Aromasin (Exemestane) FDA package insert doesn’t have numbers about how common side effects are.
The Femara (Letrozole) FDA package insert doesn’t have numbers about how common side effects are.
Risks and risk factors
No information currently available
No information currently available